| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9804 |
| Human Intestinal Absorption | HIA+ | 0.9958 |
| Caco-2 Permeability | Caco2+ | 0.9380 |
| P-glycoprotein Substrate | Non-substrate | 0.8186 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9787 |
| Non-inhibitor | 0.9895 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8749 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5620 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8232 |
| CYP450 2D6 Substrate | Non-substrate | 0.9572 |
| CYP450 3A4 Substrate | Non-substrate | 0.8312 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6246 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9741 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9671 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9492 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9806 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8599 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9382 |
| Non-inhibitor | 0.9805 |
| AMES Toxicity | Non AMES toxic | 0.9420 |
| Carcinogens | Non-carcinogens | 0.5921 |
| Fish Toxicity | High FHMT | 0.7412 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9973 |
| Honey Bee Toxicity | High HBT | 0.7236 |
| Biodegradation | Ready biodegradable | 0.7465 |
| Acute Oral Toxicity | III | 0.8846 |
| Carcinogenicity (Three-class) | Non-required | 0.7143 |